# KLOW Peptide References — Cited Literature for the Four-Component Blend | KLOW Terminal

> Full citation list for the KLOW peptide research record: BPC-157, TB-500/thymosin beta-4, GHK-Cu, and KPV component literature with DOIs, PMIDs, and URLs. KLOW peptide sources.

## Study references

All citations used across this site, indexed by number. Each citation is from our research corpus and links to the primary source.

## References

[1] Hsieh MJ, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep. 2020;10:17078. https://pubmed.ncbi.nlm.nih.gov/33051481/
[2] Hsieh MJ, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep. 2020;10:17078. https://pubmed.ncbi.nlm.nih.gov/33051481/
[3] Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3). https://pubmed.ncbi.nlm.nih.gov/10469335/
[4] Jo JO, et al. Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner. Biochim Biophys Acta. 2010. https://pubmed.ncbi.nlm.nih.gov/20691219/
[5] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
[6] Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. https://pubmed.ncbi.nlm.nih.gov/18061177/
[7] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
[8] Author group. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions. Pharmaceuticals (Basel). 2025. https://pubmed.ncbi.nlm.nih.gov/41155565/
[9] Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21:976-983. https://pubmed.ncbi.nlm.nih.gov/14554208/
[10] World Anti-Doping Agency. 2024 Prohibited List — Section S2: Peptide Hormones, Growth Factors, Related Substances, and Mimetics. WADA. https://www.wada-ama.org/en/prohibited-list
[11] Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41966639/
[12] Smart N, et al. Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007. https://doi.org/10.1038/nature05383
[13] Grant DS, et al. Thymosin beta4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis. 2007. https://pubmed.ncbi.nlm.nih.gov/17632766/
[14] Sosne G, et al. Activation of pro-resolving pathways mediate the therapeutic effects of thymosin beta-4. Front Immunol. 2024. https://pubmed.ncbi.nlm.nih.gov/39380984/
[15] Wang L, et al. Thymosin β4 improves the survival of cutaneous flaps of rat and activates Wnt/β-catenin signaling. Arch Med Sci. 2024. https://doi.org/10.5114/aoms/186188
[16] Sever'yanova LA, Dolgintsev ME. Effects of Tripeptide Gly-His-Lys in Pain-Induced Aggressive-Defensive Behavior in Rats. Bulletin of Experimental Biology and Medicine. 2017;164(2):140-143. https://pubmed.ncbi.nlm.nih.gov/29181666/
[17] Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. https://pubmed.ncbi.nlm.nih.gov/40131143/

---

A phosphor-lit research console that queries the four-peptide KLOW literature one process at a time — each finding logged to its study, the absent blend-trial rendered as an explicit null, no clinic behind the terminal.